Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements (Tables)

v3.21.1
Restatement of Previously Issued Financial Statements (Tables)
3 Months Ended
Dec. 31, 2020
Condensed Financial Information Disclosure [Abstract]  
Schedule of restatement on the financial statements
    As
Previously
Reported
    Adjustments     As
Restated
 
Balance sheet as of December 31, 2020 (unaudited)                        
Warrant Liabilities   $     $ 31,375,000     $ 31,375,000  
Ordinary Shares Subject to Possible Redemption     197,029,190       (31,375,000 )     165,654,190  
Ordinary Shares     530       313       843  
Additional Paid-in Capital     4,716,058       18,924,687       23,640,745  
Retained Earnings (Accumulated Deficit)     283,420       (18,925,000 )     (18,641,580 )
                         
Statement of Operations for the Three Months Ended December 31, 2020                        
Change in fair value of warrant liabilities   $     $ (5,875,000 )   $ (5,875,000 )
Net loss     (201,872 )     (5,875,000 )     (6,076,872 )
                         
Cash Flow Statement for the Period from February 14, 2020 (inception) to December 31, 2020 (audited)                        
Net loss   $ (201,872 )   $ (5,875,000 )   $ (6,076,872 )
Change in fair value of warrant liabilities           5,875,000       5,875,000  
Change in value of ordinary shares subject to possible redemption     (201,870 )     (5,875,000 )     (6,076,870 )